136 related articles for article (PubMed ID: 9195372)
1. Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats.
Elliot AJ; Vo LT; Grossman VL; Bhathal PS; Grossman HJ
J Gastroenterol Hepatol; 1997 Apr; 12(4):314-8. PubMed ID: 9195372
[TBL] [Abstract][Full Text] [Related]
2. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
3. 11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.
Sacerdoti D; Jiang H; Gaiani S; McGiff JC; Gatta A; Bolognesi M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):72-5. PubMed ID: 21856435
[TBL] [Abstract][Full Text] [Related]
4. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
5. Diabetes enhances the intrahepatic vascular response to endothelin-1 in cirrhotic rats: association with the ETA receptor and pERK up-regulation.
Lee JY; Lee FY; Huo TI; Wang SS; Huang HC; Lin HC; Chuang CL; Lee SD
Liver Int; 2015 Mar; 35(3):704-12. PubMed ID: 24636620
[TBL] [Abstract][Full Text] [Related]
6. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
7. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.
Feng HQ; Weymouth ND; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G27-33. PubMed ID: 19299580
[TBL] [Abstract][Full Text] [Related]
8. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
[TBL] [Abstract][Full Text] [Related]
9. Effect of interferon gamma on intrahepatic haemodynamics of the cirrhotic rat liver.
Grossman HJ; White D; Grossman VL; Bhathal PS
J Gastroenterol Hepatol; 1998 Oct; 13(10):1058-60. PubMed ID: 9835324
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
11. Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood.
Grossman HJ; Grossman VL; Bhathal PS
J Gastroenterol Hepatol; 1992; 7(3):283-7. PubMed ID: 1611016
[TBL] [Abstract][Full Text] [Related]
12. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic flow disturbance as detected by in vivo acridine orange staining in endothelin-1-treated and cirrhotic rats.
Masuda Y; Oguma T; Kaneko H
Jpn J Pharmacol; 1998 Aug; 77(4):315-8. PubMed ID: 9749934
[TBL] [Abstract][Full Text] [Related]
14. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-induced contraction of the portal vein in cirrhosis.
Petrowsky H; Schmandra T; Lorey T; Hanisch E; Herrmann G
Eur Surg Res; 1999; 31(3):289-96. PubMed ID: 10352358
[TBL] [Abstract][Full Text] [Related]
16. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
[TBL] [Abstract][Full Text] [Related]
17. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
Rockey DC; Weisiger RA
Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
19. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
20. [Intrahepatic portal vein compliance in cirrhosis].
Zheng E; Leng X; Liu J; Xu Q; Peng J; Du R
Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):350-2. PubMed ID: 11825409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
